Research and Clinical Trials

Cord Blood Research & Clinical Trials

Upstate Cord Blood Bank

In the late 1980s, blood cancers and leukemia were treated with cord blood stem cells when patients failed bone marrow treatment or a bone marrow match could not be found. Today, over 80 diseases have been treated with cord blood units; researchers are conducting cutting-edge clinical trials in areas such as early hearing loss in infants, cerebral palsy, autism, and other conditions. Researchers continue to explore new applications for the use of cord blood stem cells. The FDA regularly reviews the results of clinical trials for new treatments.

As a public, not-for-profit blood banking facility, Upstate Cord Blood Bank in Syracuse, New York offers options to clients who are interested in donating or banking their newborn’s cord blood. Umbilical cord blood stem cells are invaluable to medical research, especially in studies seeking to advance new treatments for cancer.

We work with regional hospitals and providers to develop guidelines and agreements to enable mothers in the Central New York area to donate their cord blood to the public bank or for storage in our family bank. This makes the Upstate Cord Blood Bank a valuable resource for physicians to obtain umbilical cord blood and stem cells for advanced lifesaving treatments and research. Products collected, processed, and stored at the Upstate Cord Blood Bank will be available to physicians and researchers across the United States, as well as internationally.

Upstate Cord Blood Bank operates under strict guidelines and protocols established by state and federal health organizations for quality assurance. This includes the New York State Department of Health (NYSDOH), the Food and Drug Administration (FDA), the Foundation for the Accreditation of Cellular Therapy (FACT), the American Association of Blood Banks (AABB), the Clinical Laboratory Improvement Amendments (CLIA), and the College of American Pathologists (CAP). We submit to regular inspections and testing to ensure that our state-of-the-art facility remains a safe haven for banked cord blood.